ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,329,000 | -86.2% | 28,684 | -92.7% | 0.03% | -71.9% |
| Q1 2019 | $9,616,000 | +156.4% | 394,398 | +49.9% | 0.11% | +22.6% |
| Q4 2018 | $3,750,000 | -65.9% | 263,170 | -63.6% | 0.09% | -54.4% |
| Q3 2018 | $10,983,000 | -8.1% | 722,543 | +1.5% | 0.20% | -8.5% |
| Q2 2018 | $11,947,000 | -4.1% | 711,962 | -6.7% | 0.22% | -8.2% |
| Q1 2018 | $12,460,000 | +214.8% | 763,467 | +146.9% | 0.24% | +242.3% |
| Q4 2017 | $3,958,000 | +26.1% | 309,188 | -53.4% | 0.07% | +22.4% |
| Q4 2014 | $3,139,000 | – | 663,662 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |